DK0923730T3 - Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin - Google Patents

Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin

Info

Publication number
DK0923730T3
DK0923730T3 DK97943383T DK97943383T DK0923730T3 DK 0923730 T3 DK0923730 T3 DK 0923730T3 DK 97943383 T DK97943383 T DK 97943383T DK 97943383 T DK97943383 T DK 97943383T DK 0923730 T3 DK0923730 T3 DK 0923730T3
Authority
DK
Denmark
Prior art keywords
down syndrome
prenatal screening
hyperglycosylated gonadotropin
hyperglycosylated
gonadotropin
Prior art date
Application number
DK97943383T
Other languages
Danish (da)
English (en)
Inventor
Laurence A Cole
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of DK0923730T3 publication Critical patent/DK0923730T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/806Fertility tests
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/814Pregnancy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • Y10S436/818Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK97943383T 1996-09-06 1997-09-05 Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin DK0923730T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2556896P 1996-09-06 1996-09-06
PCT/US1997/016657 WO1998010282A1 (fr) 1996-09-06 1997-09-05 Depistage prenatal du syndrome de down a l'aide de gonadotrophine hyperglycosylee

Publications (1)

Publication Number Publication Date
DK0923730T3 true DK0923730T3 (da) 2009-02-09

Family

ID=21826817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97943383T DK0923730T3 (da) 1996-09-06 1997-09-05 Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin

Country Status (10)

Country Link
US (1) US6429018B1 (fr)
EP (2) EP1992944A1 (fr)
JP (2) JP3950481B2 (fr)
AT (1) ATE412896T1 (fr)
CA (1) CA2264840C (fr)
DE (1) DE69739072D1 (fr)
DK (1) DK0923730T3 (fr)
ES (1) ES2317656T3 (fr)
PT (1) PT923730E (fr)
WO (1) WO1998010282A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
CA2369923A1 (fr) * 1999-04-12 2000-10-19 Trustees Of Columbia University In The City Of New York Detection de cancer et de grossesse anormale au moyen d'anticorps monoclonaux specifiques pour des isoformes de la hcg
US20020098513A1 (en) * 2000-02-17 2002-07-25 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
WO2003012445A1 (fr) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Procedes et trousses de detection des ita dans un echantillon biologique
US7314760B2 (en) * 2003-06-10 2008-01-01 Stc. Unm Biochemical test for identifying pregnancies with Down's syndrome fetus
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
AT500321B1 (de) * 2003-12-30 2006-02-15 Red Bull Gmbh Verfahren zur diagnose des down-syndroms
US20050148096A1 (en) * 2004-01-07 2005-07-07 Cole Laurence A. Methods for detecting pregnancy
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US7666683B1 (en) 2004-10-13 2010-02-23 Stc.Unm Rapid method of diagnosing a normal pregnancy with high accuracy
US20060105411A1 (en) * 2004-11-15 2006-05-18 Cole Laurence A Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
AU2006278260B2 (en) * 2005-08-08 2012-03-08 Onconon, Llc. Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
WO2009040133A1 (fr) * 2007-09-26 2009-04-02 Universitätsklinikum Heidelberg Ostéopontine en tant que nouveau biomarqueur de pronostic de l'insuffisance cardiaque
US8269163B2 (en) * 2008-05-03 2012-09-18 New York University Biomarkers of ionizing radiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
US5506150A (en) * 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
US5445968A (en) * 1989-01-03 1995-08-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Purification of human chorionic gonadotropin β-core molecule and preparation of antibodies with specificity for same
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
JP3537535B2 (ja) 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法
US5674727A (en) * 1994-08-31 1997-10-07 Cole; Laurence A. Human chorionic gonadotropin beta-subunit nicking enzyme

Also Published As

Publication number Publication date
EP0923730B1 (fr) 2008-10-29
US6429018B1 (en) 2002-08-06
ATE412896T1 (de) 2008-11-15
EP0923730A1 (fr) 1999-06-23
EP0923730A4 (fr) 1999-10-13
CA2264840C (fr) 2006-04-04
DE69739072D1 (de) 2008-12-11
WO1998010282A1 (fr) 1998-03-12
ES2317656T3 (es) 2009-04-16
JP2007163505A (ja) 2007-06-28
CA2264840A1 (fr) 1998-03-12
JP2001506744A (ja) 2001-05-22
PT923730E (pt) 2008-12-04
EP1992944A1 (fr) 2008-11-19
JP3950481B2 (ja) 2007-08-01

Similar Documents

Publication Publication Date Title
DK0923730T3 (da) Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin
DE69931910D1 (en) Pränatales screening für downs-syndrom
ES2189799T3 (es) Metodo para detectar sindrome de down utilizando muestras de sangre seca.
IT1270130B (it) Strumento diagnostico automatizzato in particolare per l'analisi di campioni in pacchi di prova per un analita
DE69031984D1 (de) Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
ES2047334T3 (es) Metodo de analisis optico.
DE3688330D1 (de) Anordnung und verfahren fuer die analyse biologischer specimen.
ATE64655T1 (de) Verfahren zum fixieren von proben fuer die fluoreszenzmikroskopie und nach diesem verfahren hergestellte probenstrukturen.
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
ATE163971T1 (de) Verfahren zur isolierung von fetalen zytotrophoblastzellen
DE69832161D1 (de) Pränatale diagnostische verfahren in vitro
DE69525400T2 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
WO1999064860A3 (fr) Test previsionnel de pre-eclampsie
WO1999054707A3 (fr) Epreuve foetale de prevision de poids faible a la naissance
DE69721889D1 (de) Pränatales Testverfahren für Down-Syndrom
UA9032A (uk) Спосіб прогнозування внутрішньочеревного розвитку опорно-рухового апарату плоду
CA2191061A1 (fr) Procede de test genetique